BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8114836)

  • 21. Mixed autologous allogeneic bone marrow transplantation in rabbits.
    Gratwohl A; Baldomero H; Speck B
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3079-81. PubMed ID: 2523172
    [No Abstract]   [Full Text] [Related]  

  • 22. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immunological aspects of bone marrow transplantation].
    Okulov VB; Afanas'ev BV
    Vopr Onkol; 1992; 38(4):387-96. PubMed ID: 1300731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications and results in bone marrow transplantation].
    Jeannet M; Chapuis B
    Ther Umsch; 1986 Feb; 43(2):138-43. PubMed ID: 3515608
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow transplantation in chronic GvHD and autoimmune diseases.
    Andolina M; Maximova N; Rabusin M; Parco S; Colovic M; Jankovic G
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():145-7. PubMed ID: 8932817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation: acute and late complications.
    Tabbara IA
    Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 28. [Graft-versus-host reaction as a complication of bone marrow transplantation].
    Bogdanić V; Dobrić I; Labar B
    Lijec Vjesn; 1984 Jun; 106(6):238-40. PubMed ID: 6381946
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
    Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ophthalmologic complications of bone marrow transplant].
    Castier P; Jouet JP; Janin-Mercier A; Bochu F; Mancel E
    Bull Soc Ophtalmol Fr; 1989 Feb; 89(2):291-4. PubMed ID: 2805205
    [No Abstract]   [Full Text] [Related]  

  • 31. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogenic bone marrow transplantation].
    Yamane T; Im T; Nakao T; Kumura T; Tatsumi N
    Rinsho Byori; 1995 Jul; Suppl 99():15-23. PubMed ID: 7474421
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience using bone marrow transplantation in the treatment of hematologic neoplasms and solid tumors].
    Niederwieser D; Aulitzky W; Frommhold H; Schönitzer D; Url M; Allerberger F; Wiegele J; Gratwohl A; Braunsteiner H; Huber C
    Wien Klin Wochenschr; 1987 Jan; 99(2):49-53. PubMed ID: 3551339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histocompatibility barriers in human marrow transplantation.
    Feig SA
    Am J Pediatr Hematol Oncol; 1980; 2(3):273-80. PubMed ID: 7001944
    [No Abstract]   [Full Text] [Related]  

  • 35. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
    J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance to engraftment in irradiated dogs receiving T cell-depleted bone marrow transplants.
    Bradstock KF; Prendergast MM; Hughes WG; Broomhead AF; Kabral A; Tiver K
    Transplant Proc; 1987 Apr; 19(2):2902-6. PubMed ID: 3551233
    [No Abstract]   [Full Text] [Related]  

  • 37. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
    Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Graft-versus-host disease].
    Svedentsov EP; Sharygin SL; Epifanov NS; Matveev GA
    Klin Med (Mosk); 1993; 71(5):19-23. PubMed ID: 8301977
    [No Abstract]   [Full Text] [Related]  

  • 39. Late development of graft-versus-host disease in an autologous BMT recipient.
    Appleton AL; Sviland L; Wilkes J; Pearson AD; Malcolm AJ
    Bone Marrow Transplant; 1994 Jun; 13(6):823-5. PubMed ID: 7920321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indication of bone marrow transplantation].
    Masaoka T
    Rinsho Byori; 1995 Jul; Suppl 99():1-7. PubMed ID: 7474413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.